| Name | Title | Contact Details |
|---|---|---|
Karl Buchanan |
Chief Operating Officer | Profile |
Robert Reynolds, a high-stakes corporate lawyer with law firms such as Alston & Bird and Seyfarth Shaw, and award-winning innovator in the legal space, founded Tangible Global in 2014 with the mission to bring the practice of law into modern times delivering "Law at the speed of business." Joining Robert as Partner, Denise Barnes brings over 20 years of experience as a seasoned entrepreneur in B2B service delivery. Her marketing firm was the first to offer marketing automation, managed services, and digital applications to clients such as Microsoft, Oracle, and Google. With its recent acquisition of AUTTO, a leading no-code technology and applications provider, Tangible further strengthened its technology and software development leadership by adding Ian Gosling as CPO and Krisztian Kerek as CTO. Nike, one of Tangibles early adopters, embraced and understood that Tangible represented a better alternative to the traditional law firm providing great value especially for portfolios of recurring transactions. Nike has continued to partner with Tangible over the last 10 years. AUTTO has been embraced by the global law firms of Eversheds Sutherland and Dentons as well as Petronas. By combining no-code workflow automation capabilities with extensive legal expertise across many industries, Tangible continues to evolve its broad portfolio of digital applications that support various aspects of commercial transactions and legal operations. AUTTOs technology has enabled Tangible to develop digital services to replace "time with tech." By combining AUTTOs workflow automation capabilities with extensive legal expertise across many industries, the firm has developed a broad portfolio of digital services to support various aspects of commercial transactions and legal operations, including an AI risk management service. Headquartered in Portland, OR, Tangibles team members are distributed across the US, with a notable presence in New York, London, Boston, and Chicago.
Pickleball is a journey. Let us meet you where you are. Whether youre just getting started or have been playing for years, weve got you covered with the paddles, accessories, apparel, footwear, and more to help you play your best. Our trusted experts have your back. We love this game. With a history that spans almost as long as the sport itself, we proudly stand on a mission to provide expert-approved gear––selected by players, for players. More than just shopping. * Helpful product selection quizzes * 30-Day Paddle Test Drive Policy * Loyalty Rewards Program * Expert tips, tricks, and product reviews * Unrivaled customer service * Free balls with paddle purchase* *some exclusions apply Please contact us with any questions at (888) 854-0163. We know it can be hard to choose a pickleball paddle and our knowledgeable customer service experts are ready to help. With our Risk-Free 30-Day Paddle Return Policy, you can try a paddle for 30 days and if its not the right paddle for you, return it for exchange or full refund.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Mission Statement The mission of American 1 Credit Union is to create financial wellness in our communities through personal everyday banking. From our beginning in 1950 to where we are today, serving over 62,000 people in five Michigan counties, American 1 Credit Union has been committed to providing excellent, low-cost everyday banking for our members. For more information on who we are, please visit - https://www.american1cu.org/about-us/who-we-are All loans are subject to approval. American 1 Disclosures - http://a1cu.us/Disclosures American 1 Privacy Policy - http://a1cu.us/Privacy-Policy This credit union is federally insured by the National Credit Union Administration. Equal Housing Opportunity. USA Patriot Act: Member Identification Requirements In accordance with Section 326 of the USA Patriot Act, applicants for new accounts are requested to provide current picture identification that verifies identity including name, address, and other identifying information. In some cases, identification will be requested for current members if original documentation was not obtained with the opening of the account. In all cases, protection of our members identity and confidentiality is our pledge to you. We proudly support all efforts to protect and maintain the security of our members and our country.